Episode Details

Richard Oberreitter: New Frontiers in Vascular Health

Ep. 22

In October of 2019, Modulim, a recognized leader in optical imaging solutions for noninvasive tissue assessment, announced the appointment of Richard Oberreiter as its new CEO. Modulim is a pioneer in subsurface optical imaging powered by SFDI, an advanced imaging technique co-invented by founder and CTO David Cuccia, Ph.D. SFDI is a noninvasive tissue oxygen saturation technology that combines structured illumination with multiple wavelengths of light (visible and near-infrared) to allow for deeper and layer-specific assessment of tissue oxygenation and hemoglobin. Modulim's goal is to help clinicians reduce the number and severity of diabetic foot ulcers (DFUs).

In this episode of DeviceAlliance’s Medtech Radio, we speak with the CEO of Modulim, Richard Oberreiter, J.D., M.B.A. Richard has for over 20 years successfully led new ventures and orchestrated turnarounds. Join us as we discuss the life lessons learned from his time as a US Navy Officer, leading a medtech team from the front, and never giving up the ship.


Follow the great work Richard and team are doing at Modulim.

Book Recommendation:

Thanks for listening! Please share our podcast on LinkedIn, Twitter, and Facebook, and stay tuned for our next episode!


  • All
  • Entrepreneurship/Startups
  • Leadership Spotlight
  • Marketing & Product Development
  • Professional Development
  • Women in MedTech
  • Young Professionals

Live DA Event: Critical Thinking on Clinical Trial Success | Ep.43

You’ve got a great idea for a medical device!  Now what? Most errors in clinical trials are a result of poor planning. Fancy statistical methods cannot rescue design flaws. Thus careful planning with clear foresight is absolutely crucial for clinical trial success.   With the explosion of Medtech opportunities for startups, what are the current